| Period Ending | Dec 30, 2012 | Dec 30, 2011 | Dec 30, 2010 |
|---|
|
Total Revenue
|
27,490,000
|
21,086,000
|
22,479,000
| | Cost of Revenue | 24,683,000 | 20,036,000 | 19,192,000 | | |
Gross Profit
|
2,807,000
|
1,050,000
|
3,287,000
| |
|
Operating Expenses |
|
Research Development | 733,000 | 708,000 | 677,000 |
|
Selling General and Administrative | 1,551,000 | 1,159,000 | 1,470,000 |
|
Non Recurring |
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
| | | |
Operating Income or Loss
|
522,000
|
(817,000)
|
1,141,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 274,000 | 180,000 | 212,000 |
|
Earnings Before Interest And Taxes | 836,000 | (623,000) | 1,369,000 |
|
Interest Expense | 408,000 | 315,000 | 254,000 |
|
Income Before Tax | 428,000 | (938,000) | 1,115,000 |
|
Income Tax Expense | 208,000 | (254,000) | 94,000 |
|
Minority Interest |
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 261,000 | (670,000) | 1,037,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
| | | |
Net Income
|
221,000
|
(684,000)
|
1,021,000
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
221,000
|
(684,000)
|
1,021,000
|
|